June 22, 2022 – Truveta has announced a strategic collaboration with Pfizer to deliver new safety insights on a continuous basis, using verifiable real-world data at scale. Truveta will provide Pfizer with an unprecedented data platform for research. The data collected by Truveta are always flowing, providing the most up-to-date picture of U.S. health. Pfizer will use de-identified data from Truveta to identify, monitor, and evaluate potential signals in near-real time, informing efforts to mitigate risks and enabling further research.
Truveta is the world’s first health system-led data platform with a vision of Saving Lives with Data. Truveta’s 20 innovative health system members provide more than 16 percent of U.S. patient care from tens of thousands of clinical care sites across 42 states and provide ongoing governance to Truveta.
Truveta’s data platform empowers researchers to quickly monitor, query and evaluate health data from more than 50 million de-identified patient journeys, covering a broad range of diversity of the U.S. Data are updated daily and includes the full Electronic Medical Record (EMR), not just the medical bill from claims data, all fully anonymized and aggregated. This clinical data is linked across providers and with medical claims when care is provided outside Truveta’s network. Every patient record is enhanced with comprehensive socio-economic data and daily mortality data for a complete picture of each patient’s health journey.
In close partnership with its health system members, Truveta puts the researcher front and center in their efforts – creating the opportunity to access data for real-time learning. Truveta’s learning community connects life science and health systems to innovate collaboratively, speed time to insights, and earn trust through transparency and reproducibility of research.